Skip to main content
Premium Trial:

Request an Annual Quote

4basebio Q3 Revenues Down 5 Percent, Firm Approves Spinoff of DNA Manufacturing Business

NEW YORK — 4basebio on Thursday posted a 5 percent year-over-year decline in revenues for the third quarter, reflecting a reduction in US sales following the closure of the company's San Diego site. In addition, it has approved the spinoff of its DNA manufacturing business.

For the three-month period ended September 30, 4basebio's revenues fell to €289,000 ($340,800) from €305,000 a year earlier, as a bulk sale of enzymes from the company's Spanish operations partially offset the lower US sales.

Early this year, Heidelberg, Germany-based 4basebio — then known as Expedeon — sold its proteomics and immunology businesses to Abcam for €120 million in cash in order to focus on the manufacture and supply of DNA for research and therapeutic applications through its Madrid-based unit. The company later shut down its San Diego operations.

4basebio's net loss for the quarter was flat compared to a year ago at €1.3 million. Total operating expenses in the quarter were also unchanged year over year at €1.5 million.

As of September 30, 4basebio had cash and cash equivalents totaling €75.7 million.

"During the course of Q3, the business continued to invest in its DNA technology, with a focus on the ongoing validation and increasing scaling of DNA manufacturing … and [remains] on track to produce GMP grade DNA during the course of 2021," 4basebio CEO Heikki Lanckriet said in a statement. "As a result of the Abcam transaction, we are well financed."

4baseBio noted that an extraordinary general company meeting on Nov. 3 approved the spinoff and separate listing of the company's DNA operating business on the UK Alternative Investment Market, a plan announced this summer, which the firm said will result in changes to "the shape of the company" in Q4.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.